Statins: Monotherapy or Combination Strategy for the Treatment of Dyslipidemia

Publisher： Karger

E-ISSN： 1424-0556|2|4|175-183

ISSN： 1422-9528

Source： Heart Drug, Vol.2, Iss.4, 2002-11, pp. : 175-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fenofibric Acid: In Combination Therapy in the Treatment of Mixed Dyslipidemia

By Yang Lily P.H.   Keating Gillian M.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 6, 2009-12 ,pp. : 401-409

Adis International

Access to resources Recommend Favorite

Which Strategy Is More Effective for the Treatment of Cardiovascular Disease: High-Dose Angiotensin II Type 1 Receptor Antagonist Monotherapy or Combination Therapy?

By Miura Shin-ichiro   Saku Keijiro  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 2, 2008-01 ,pp. : 88-90

Adis International

Access to resources Recommend Favorite

Monotherapy versus Combination Therapy as First Line Treatment of Uncomplicated Arterial Hypertension

By Ruzicka M.  

Drugs, Vol. 61, Iss. 7, 2001-01 ,pp. : 943-954

Adis International

Access to resources Recommend Favorite

The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges

By Ahmed Mohamed H   Al-Atta Ayman   Hamad Mahir A  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1901-1909

Informa Healthcare

Access to resources Recommend Favorite

A Review on the Use of Statins and Tocotrienols, Individually or in Combination for the Treatment of Osteoporosis

By  

Current Drug Targets, Vol. 14, Iss. 13, 2013-12 ,pp. : 1579-1590

Bentham Science Publishers

Access to resources Recommend Favorite